Cargando…

Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches

Non-Alcoholic Fatty Liver Disease (NAFLD) is currently the most common cause of chronic liver disease worldwide, and its prevalence is increasing globally. NAFLD is a multifaceted disorder, and its spectrum includes steatosis to steatohepatitis, which may evolve to advanced fibrosis and cirrhosis. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinou, Eirini, Pericleous, Marinos, Stefanova, Irena, Kaur, Vasha, Angelidi, Angeliki M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871470/ https://www.ncbi.nlm.nih.gov/pubmed/35204498 http://dx.doi.org/10.3390/diagnostics12020407

Ejemplares similares

Neurohormonal Changes in the Gut–Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery
por: Martinou, Eirini, et al.
Publicado: (2022)

A Systematic Review on HOX Genes as Potential Biomarkers in Colorectal Cancer: An Emerging Role of HOXB9
por: Martinou, Eirini, et al.
Publicado: (2021)

HOXB9 Overexpression Promotes Colorectal Cancer Progression and Is Associated with Worse Survival in Liver Resection Patients for Colorectal Liver Metastases
por: Martinou, Eirini, et al.
Publicado: (2022)

Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease
por: Kranidiotis, Georgios, et al.
Publicado: (2013)

Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease
por: Cheah, Mark CC, et al.
Publicado: (2017)

A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
por: Ganguli, Surosree, et al.
Publicado: (2019)

The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
por: Perakakis, Nikolaos, et al.
Publicado: (2020)

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease
por: Poynard, Thierry, et al.
Publicado: (2006)

Non-Invasive Diagnostic Test for Advanced Fibrosis in Adolescents With Non-Alcoholic Fatty Liver Disease
por: Mosca, Antonella, et al.
Publicado: (2022)

Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease
por: Hussain, Mazhar, et al.
Publicado: (2016)

Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease
por: Grąt, Karolina, et al.
Publicado: (2020)

Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
por: Jamshidi, Neema, et al.
Publicado: (2023)

Anthropometric and Biochemical Characteristics of Patients with Nonalcoholic Fatty Liver Diagnosed by Non-Invasive Diagnostic Methods
por: Novakovic, Tatjana, et al.
Publicado: (2014)

Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease
por: Zhang, Xuelin, et al.
Publicado: (2016)

Multi-Omics Reveals Inhibitory Effect of Baicalein on Non-Alcoholic Fatty Liver Disease in Mice
por: Li, Ping, et al.
Publicado: (2022)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Emerging Diagnostics and Therapeutics for Non-alcoholic Fatty Liver Disease
por: Darbhanga, Jake, et al.
Publicado: (2023)

Non-invasive tests of non-alcoholic fatty liver disease
por: Li, Guanlin, et al.
Publicado: (2022)

Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents
por: Jain, Vandana, et al.
Publicado: (2018)

Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes
por: Wruck, Wasco, et al.
Publicado: (2015)

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Ratziu, Vlad, et al.
Publicado: (2006)

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020)

Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
por: Kechagias, Stergios, et al.
Publicado: (2022)

Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
por: Katsarou, Angeliki, et al.
Publicado: (2020)

Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity
por: Kim, Ju Young, et al.
Publicado: (2018)

Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study
por: Ciećko-Michalska, Irena, et al.
Publicado: (2018)

Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?
por: Papachristodoulou, Angeliki, et al.
Publicado: (2021)

Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD)
por: Hashemi kani, Ali, et al.
Publicado: (2013)

Multi-Omics Approach Reveals Dysregulation of Protein Phosphorylation Correlated with Lipid Metabolism in Mouse Non-Alcoholic Fatty Liver
por: Kim, Sora Q., et al.
Publicado: (2022)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Diagnostic Accuracy of Vibration Controlled Transient Elastography as Non-invasive Assessment of Liver Fibrosis in Patients with Non-alcoholic Fatty Liver Disease
por: Salehi, Hossain, et al.
Publicado: (2023)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis
por: Vogli, Stamatina, et al.
Publicado: (2023)

Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach
por: Stols-Gonçalves, Daniela, et al.
Publicado: (2023)

Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach
por: Grgurevic, Ivica, et al.
Publicado: (2021)

Association Between Non-invasive Diagnostic Methods of Liver Fibrosis and Type 2 Diabetes in Pediatric Patients With Non-alcoholic Fatty Liver Disease
por: Yang, Aram, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_peg2hoovjq469bgj5hsd3n5mce